The lower level of decorin protein in COPD patients compared to healthy controls (supplementary table S3) may have a negative impact on COPD muscle mass, as decorin binds to myostatin, neutralising its function, and also induces the expression of MYOD1 and follistatin [5, 24]. Here, MSTN is linked to chronic obstructive pulmonary disease.